May 12, 2026 a 09:00 am
STE: Analysts Ratings - STERIS plc
STERIS plc, a key player in the infection prevention industry, offers a wide range of products and services across its four segments. With its solid market presence and strategic offerings, the company's stock has been under active analyst scrutiny. Current recommendations indicate a cautious optimism, reflecting both the potential and challenges in the healthcare equipment sector.
Historical Stock Grades
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 3 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
Over recent months, sentiment towards STERIS plc has maintained a steady pace with slight variations in analyst ratings. Despite occasional fluctuations, the stock reflects a relatively stable sentiment with a balance between buy and hold advisories.
- Strong Buy ratings have seen a minor decline over the last months, now stabilizing at two.
- Buy ratings have consistently held at three, indicating subdued but ongoing support for the stock.
- Hold recommendations have intermittently increased, suggesting cautious optimism or reassessment among analysts.
Percentage Trends
Analyzing the percentage distribution shows that the bullish sentiment, while ongoing, has slightly receded in favor of more neutral positions. This shift signifies a nuanced approach towards risk management amidst market dynamics.
- Strong Buy ratings have decreased from 33% to 22% over the past months.
- The proportion of Hold ratings has seen a notable rise, now representing 22%, which underscores a lean towards caution.
- The advent of Strong Sell ratings, albeit minor, indicates a growing layer of skepticism.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-08 | Overweight | Overweight | Morgan Stanley |
| 2025-07-22 | Overweight | Overweight | Keybanc |
| 2025-07-15 | Overweight | Equal Weight | Morgan Stanley |
| 2025-05-19 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-05-16 | Market Outperform | Market Outperform | JMP Securities |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-15 | Overweight | Equal Weight | Morgan Stanley |
| 2024-10-24 | Overweight | Neutral | Piper Sandler |
| 2023-04-14 | Neutral | Overweight | Piper Sandler |
| 2022-09-23 | Hold | Buy | Needham |
| 2021-05-26 | Buy | Hold | Needham |
Interpretation
The analyst ratings for STERIS plc reveal a cautious but optimistic outlook. Despite fluctuations, the recommendation trends suggest a generally stable stance rather than any significant volatility in sentiment. The introduction of Strong Sell ratings, albeit minimal, hints at emerging concerns among some analysts. Overall, the sentiment reflects a balanced perspective, neither aggressively bullish nor overly bearish.
Conclusion
STERIS plc finds itself in a stable yet finely poised situation. Most analysts maintain a cautiously optimistic view, with recommendations spanning from holding to overweighting positions. The company’s consistent delivery in its market segments and wide product portfolio offers growth potential. However, the advent of a slight uptick in hold and sell advisories signals potential caution due to evolving market conditions or internal company adjustments. Thus, investors should weigh these mixed signals with an understanding of sector-specific challenges and opportunities.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years